Cargando...
Human papillomavirus vaccine initiation among 9–13-year-olds in the United States
The quadrivalent and 9-valent human papillomavirus (HPV) vaccines are licensed for administration among 9–26-year-old males and females, with routine vaccination recommended for 11–12-year-olds. Despite the availability of the vaccine at younger ages, few studies have explored vaccine uptake prior t...
Gardado en:
| Publicado en: | Prev Med Rep |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4652326/ https://ncbi.nlm.nih.gov/pubmed/26594616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pmedr.2015.10.003 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|